The global Equols market size was valued at US$ 323.8 million in 2023. With growing demand in downstream market, the Equols is forecast to a readjusted size of US$ 514.8 million by 2030 with a CAGR of 6.8% during review period.
The research report highlights the growth potential of the global Equols market. Equols are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Equols. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Equols market.
Equol ,a metabolite of soybeans, is an important isoflavone in humans锛宻pecifically binds to 5伪-DHT, has a modest affinity for recombinant estrogen receptor ER尾. Equol is a metabolite produced from the soy phytoestrogen daidzein by the action of gut microflora. Equol has higher affinity for both ERs (estrogen receptors including ERalpha and ERbeta). Equol exists as the enantiomers R-equol and S-equol. S-equol has a high binding affinity, preferential for ERbeta with a Ki of 16 nM whereas R-equol binds more weakly and with a preference for ERalpha K with a Ki of 50 nM. Equol is superior to all other isoflavones in its antioxidant activity. Equol has antioestrogenic properties. Equol is a 100-fold more potent than daidzein in stimulating an oestrogenic response. Equol is also more effective than daidzein in competing with 3 H-oestradiol for binding to the ER. Equol stimulates the growth of MCF-7 cells in a concentration-dependent manner. Although equol exhibits oestrogenic activity, exposure of MCF-7 cells to equol simultaneously with oestradiol is effective in reducing pS2 mRNA expression. Equol results in the downregulation of ER mRNA expression.
Equol, a compound produced by certain individuals鈥� gut bacteria, has gained interest for its potential health benefits, particularly in hormone regulation and cardiovascular health. While equol is not widely available as a standalone product, there has been research exploring its potential use in dietary supplements and functional foods.
The global equol market is still emerging, and its size and growth potential can be influenced by various factors such as consumer awareness, regulatory frameworks, research advancements, and industry collaborations. The market鈥檚 development may also be dependent on the availability and commercialization of equol-producing probiotics or other technologies that enhance equol production.
As interest in personalized nutrition and gut health continues to rise, it is conceivable that the equol market may experience growth in the future.
Key Features:
The report on Equols market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Equols market. It may include historical data, market segmentation by Type (e.g., (S)-equol, (R)-equol), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Equols market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Equols market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Equols industry. This include advancements in Equols technology, Equols new entrants, Equols new investment, and other innovations that are shaping the future of Equols.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Equols market. It includes factors influencing customer ' purchasing decisions, preferences for Equols product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Equols market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Equols market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Equols market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Equols industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Equols market.
Market Segmentation:
Equols market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
(S)-equol
(R)-equol
Segmentation by application
Producing Bacteria
Anti-aging Supplements
Skin Health
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Tocris Bioscience
Cayman Chemical
Selleck Chemicals
Merck
Santa Cruz Biotechnology, Inc.
Dr Tobias
Otsuka
TCI Chemicals
LKT Laboratories
AdooQ BioScience
Key Questions Addressed in this Report
What is the 10-year outlook for the global Equols market?
What factors are driving Equols market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Equols market opportunities vary by end market size?
How does Equols break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Equols Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Equols by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Equols by Country/Region, 2019, 2023 & 2030
2.2 Equols Segment by Type
2.2.1 (S)-equol
2.2.2 (R)-equol
2.3 Equols Sales by Type
2.3.1 Global Equols Sales Market Share by Type (2019-2024)
2.3.2 Global Equols Revenue and Market Share by Type (2019-2024)
2.3.3 Global Equols Sale Price by Type (2019-2024)
2.4 Equols Segment by Application
2.4.1 Producing Bacteria
2.4.2 Anti-aging Supplements
2.4.3 Skin Health
2.4.4 Other
2.5 Equols Sales by Application
2.5.1 Global Equols Sale Market Share by Application (2019-2024)
2.5.2 Global Equols Revenue and Market Share by Application (2019-2024)
2.5.3 Global Equols Sale Price by Application (2019-2024)
3 Global Equols by Company
3.1 Global Equols Breakdown Data by Company
3.1.1 Global Equols Annual Sales by Company (2019-2024)
3.1.2 Global Equols Sales Market Share by Company (2019-2024)
3.2 Global Equols Annual Revenue by Company (2019-2024)
3.2.1 Global Equols Revenue by Company (2019-2024)
3.2.2 Global Equols Revenue Market Share by Company (2019-2024)
3.3 Global Equols Sale Price by Company
3.4 Key Manufacturers Equols Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Equols Product Location Distribution
3.4.2 Players Equols Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Equols by Geographic Region
4.1 World Historic Equols Market Size by Geographic Region (2019-2024)
4.1.1 Global Equols Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Equols Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Equols Market Size by Country/Region (2019-2024)
4.2.1 Global Equols Annual Sales by Country/Region (2019-2024)
4.2.2 Global Equols Annual Revenue by Country/Region (2019-2024)
4.3 Americas Equols Sales Growth
4.4 APAC Equols Sales Growth
4.5 Europe Equols Sales Growth
4.6 Middle East & Africa Equols Sales Growth
5 Americas
5.1 Americas Equols Sales by Country
5.1.1 Americas Equols Sales by Country (2019-2024)
5.1.2 Americas Equols Revenue by Country (2019-2024)
5.2 Americas Equols Sales by Type
5.3 Americas Equols Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Equols Sales by Region
6.1.1 APAC Equols Sales by Region (2019-2024)
6.1.2 APAC Equols Revenue by Region (2019-2024)
6.2 APAC Equols Sales by Type
6.3 APAC Equols Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Equols by Country
7.1.1 Europe Equols Sales by Country (2019-2024)
7.1.2 Europe Equols Revenue by Country (2019-2024)
7.2 Europe Equols Sales by Type
7.3 Europe Equols Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Equols by Country
8.1.1 Middle East & Africa Equols Sales by Country (2019-2024)
8.1.2 Middle East & Africa Equols Revenue by Country (2019-2024)
8.2 Middle East & Africa Equols Sales by Type
8.3 Middle East & Africa Equols Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Equols
10.3 Manufacturing Process Analysis of Equols
10.4 Industry Chain Structure of Equols
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Equols Distributors
11.3 Equols Customer
12 World Forecast Review for Equols by Geographic Region
12.1 Global Equols Market Size Forecast by Region
12.1.1 Global Equols Forecast by Region (2025-2030)
12.1.2 Global Equols Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Equols Forecast by Type
12.7 Global Equols Forecast by Application
13 Key Players Analysis
13.1 Tocris Bioscience
13.1.1 Tocris Bioscience Company Information
13.1.2 Tocris Bioscience Equols Product Portfolios and Specifications
13.1.3 Tocris Bioscience Equols Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Tocris Bioscience Main Business Overview
13.1.5 Tocris Bioscience Latest Developments
13.2 Cayman Chemical
13.2.1 Cayman Chemical Company Information
13.2.2 Cayman Chemical Equols Product Portfolios and Specifications
13.2.3 Cayman Chemical Equols Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Cayman Chemical Main Business Overview
13.2.5 Cayman Chemical Latest Developments
13.3 Selleck Chemicals
13.3.1 Selleck Chemicals Company Information
13.3.2 Selleck Chemicals Equols Product Portfolios and Specifications
13.3.3 Selleck Chemicals Equols Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Selleck Chemicals Main Business Overview
13.3.5 Selleck Chemicals Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Equols Product Portfolios and Specifications
13.4.3 Merck Equols Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Santa Cruz Biotechnology, Inc.
13.5.1 Santa Cruz Biotechnology, Inc. Company Information
13.5.2 Santa Cruz Biotechnology, Inc. Equols Product Portfolios and Specifications
13.5.3 Santa Cruz Biotechnology, Inc. Equols Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Santa Cruz Biotechnology, Inc. Main Business Overview
13.5.5 Santa Cruz Biotechnology, Inc. Latest Developments
13.6 Dr Tobias
13.6.1 Dr Tobias Company Information
13.6.2 Dr Tobias Equols Product Portfolios and Specifications
13.6.3 Dr Tobias Equols Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Dr Tobias Main Business Overview
13.6.5 Dr Tobias Latest Developments
13.7 Otsuka
13.7.1 Otsuka Company Information
13.7.2 Otsuka Equols Product Portfolios and Specifications
13.7.3 Otsuka Equols Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Otsuka Main Business Overview
13.7.5 Otsuka Latest Developments
13.8 TCI Chemicals
13.8.1 TCI Chemicals Company Information
13.8.2 TCI Chemicals Equols Product Portfolios and Specifications
13.8.3 TCI Chemicals Equols Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 TCI Chemicals Main Business Overview
13.8.5 TCI Chemicals Latest Developments
13.9 LKT Laboratories
13.9.1 LKT Laboratories Company Information
13.9.2 LKT Laboratories Equols Product Portfolios and Specifications
13.9.3 LKT Laboratories Equols Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 LKT Laboratories Main Business Overview
13.9.5 LKT Laboratories Latest Developments
13.10 AdooQ BioScience
13.10.1 AdooQ BioScience Company Information
13.10.2 AdooQ BioScience Equols Product Portfolios and Specifications
13.10.3 AdooQ BioScience Equols Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 AdooQ BioScience Main Business Overview
13.10.5 AdooQ BioScience Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
